Since concept discussions in 2016, the DDC founders have seen the future, carefully planned for it, and invested in it. They believed then and now that:-
- Local and global pharmaceutical industry profitability is constantly increasing;
- GCC and MENA steady population growth creates a long-term growing demand for generics;
- A new pharmaceutical project is beneficial for society.
- In 2016, as part of their long-term investment strategy, they established a trading division. The Saudi Company for Equilibrium
Development (SCED).
- The wholly-owned, dedicated SCED distribution network is now a fully operational, profitable, stand-alone asset and a key component for the success of the DDC project.